← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #122 OF 1,000 MOST-CITED

Lack of quality control unit

FDA cited this observation 191 times across 180 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs191
BY FISCAL YEAR
FY202610
FY202528
FY202424
FY202313
FY202219
FY20218
FY202013
FY201931
FY201829
FY201716

How FDA worded it — real examples

There is no quality control unit.

My CHS Rx, Inc. · Hauppauge, New York · Drugs · 2026-06-05

There is no quality control unit.

PReye LLC · Wheat Ridge, Colorado · Drugs · 2026-03-19

There is no quality control unit.

SURETEC INNOVATIONS LLC · Gilbert, Arizona · Drugs · 2026-03-05

There is no quality control unit.

LICO Industries, LLC · Mohave Valley, Arizona · Drugs · 2026-02-19

There is no quality control unit.

Safrel Pharmaceuticals LLC · Dayton, New Jersey · Drugs · 2026-01-30

There is no quality control unit.

Skytronics Led, Inc · Burbank, California · Drugs · 2026-01-12

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →